Trademark: 86003284
Word
ELVENTO
Status
Dead
Status Code
606
Status Date
Monday, August 24, 2015
Serial Number
86003284
Mark Type
4000
Filing Date
Friday, July 5, 2013
Published for Opposition
Tuesday, November 26, 2013
Abandoned Date
Monday, August 24, 2015

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events
Aug 24, 2015
Abandonment Notice Mailed - No Use Statement Filed
Aug 24, 2015
Abandonment - No Use Statement Filed
Jun 23, 2015
Teas Change Of Correspondence Received
Dec 10, 2014
Notice Of Approval Of Extension Request E-Mailed
Dec 9, 2014
Extension 2 Granted
Dec 2, 2014
Extension 2 Filed
Dec 2, 2014
Teas Extension Received
Jul 23, 2014
Early Extension Of Use Refused
Jul 22, 2014
Case Assigned To Intent To Use Paralegal
Jun 24, 2014
Teas Extension Received
Jun 25, 2014
Notice Of Approval Of Extension Request E-Mailed
Jun 23, 2014
Extension 1 Granted
Jun 23, 2014
Extension 1 Filed
Jun 23, 2014
Teas Extension Received
Jan 21, 2014
Noa E-Mailed - Sou Required From Applicant
Nov 26, 2013
Official Gazette Publication Confirmation E-Mailed
Nov 26, 2013
Published For Opposition
Nov 6, 2013
Notification Of Notice Of Publication E-Mailed
Oct 18, 2013
Approved For Pub - Principal Register
Oct 17, 2013
Assigned To Examiner
Jul 16, 2013
New Application Office Supplied Data Entered In Tram
Jul 9, 2013
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24